{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:47:45Z","timestamp":1785887265447,"version":"3.56.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011645","name":"Kaohsiung Medical University Hospital","doi-asserted-by":"publisher","award":["KMUH111-1R17"],"award-info":[{"award-number":["KMUH111-1R17"]}],"id":[{"id":"10.13039\/501100011645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.clim.2026.110729","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:38:39Z","timestamp":1781458719000},"page":"110729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Transcriptional immune programs underlying inadequate response to tumor necrosis factor inhibitors in ankylosing spondylitis"],"prefix":"10.1016","volume":"286","author":[{"given":"Chia-Chun","family":"Tseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Yi","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yun","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruey-Jer","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin-Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ting","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeng-Hsien","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2026.110729_bb0005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2147\/PPA.S504479","article-title":"Association of the Driving Distance, driving time, and public transit time to the hospital with the persistence of tumor necrosis factor inhibitors in patients with ankylosing spondylitis: a retrospective cohort study","volume":"19","author":"Kim","year":"2025","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.clim.2026.110729_bb0010","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s40744-023-00586-6","article-title":"Clinical and economic benefit of advanced therapies for the treatment of active ankylosing spondylitis","volume":"10","author":"Walsh","year":"2023","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.clim.2026.110729_bb0015","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/s42255-025-01245-6","article-title":"Asparagine deprivation enhances T cell antitumour response in patients via ROS-mediated metabolic and signal adaptations","volume":"7","author":"Chang","year":"2025","journal-title":"Nat. Metab."},{"key":"10.1016\/j.clim.2026.110729_bb0020","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3390\/genes13101873","article-title":"G\u00d3RNA K: VDR polymorphic variants are related to improvements in CRP and disease activity in patients with axial Spondyloarthritis that undergo anti-TNF treatment","volume":"13","author":"Bugaj","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.clim.2026.110729_bb0025","doi-asserted-by":"crossref","first-page":"970","DOI":"10.55730\/1300-0144.5661","article-title":"The impact of smoking on response to tumor necrosis factor-\u03b1 inhibitor treatment in patients with ankylosing spondylitis","volume":"53","author":"Tu\u011fsal","year":"2023","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.clim.2026.110729_bb0030","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13098-025-01720-w","article-title":"Prevalence of metabolic syndrome in ankylosing spondylitis: a multi national meta-analysis study","volume":"17","author":"Nayak","year":"2025","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.clim.2026.110729_bb0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40744-025-00810-5","article-title":"Does HLA-B27 status influence Ixekizumab efficacy in axial Spondyloarthritis? Results from the COAST-V, COAST-W, and COAST-X trials","volume":"13","author":"Reveille","year":"2026","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.clim.2026.110729_bb0040","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3390\/genes14020452","article-title":"MIF variant rs755622 is associated with severe Crohn\u2019s disease and better response to anti-TNF adalimumab therapy","volume":"14","author":"jezernik","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.clim.2026.110729_bb0045","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/biom14030382","article-title":"Molecular profiling of axial Spondyloarthritis patients reveals an association between innate and adaptive cell populations and therapeutic response to tumor necrosis factor inhibitors","volume":"14","author":"Sobral","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.clim.2026.110729_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152081","article-title":"Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration","volume":"56","author":"\u00d8rnbjerg","year":"2022","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.clim.2026.110729_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103878","article-title":"the FOXO1-SIRT1 axis in ankylosing spondylitis: a cross-platform regulator linking immunometabolism, oxidative stress, and bone remodeling","volume":"24","author":"Zhang","year":"2025","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2026.110729_bb0060","doi-asserted-by":"crossref","first-page":"1530077","DOI":"10.3389\/fmed.2025.1530077","article-title":"Expression of Tim-3 on neutrophils as a novel indicator to assess disease activity and severity in ankylosing spondylitis","volume":"12","author":"Huang","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clim.2026.110729_bb0065","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1134\/S1607672925700140","article-title":"The efficacy and safety of BCD-180, an anti-TRBV9+ T cell monoclonal antibody, in patients with active radiographic axial Spondyloarthritis: 36-week results from the randomized, double-blind, placebo-controlled phase 2 clinical study ELEFTA","volume":"522","author":"Nasonov","year":"2025","journal-title":"Dokl. Biochem. Biophys."},{"key":"10.1016\/j.clim.2026.110729_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-087872","article-title":"Rotation or change of biotherapy after TNF blocker treatment failure for axial spondyloarthritis: the ROC-SpA study, a randomised controlled study protocol","volume":"14","author":"Dalix","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.clim.2026.110729_bb0075","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ajhg.2023.12.018","article-title":"Cell-type deconvolution of bulk-blood RNA-seq reveals biological insights into neuropsychiatric disorders","volume":"111","author":"Boltz","year":"2024","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clim.2026.110729_bb0080","doi-asserted-by":"crossref","first-page":"10901","DOI":"10.3390\/ijms231810901","article-title":"Identification of a gene panel predictive of triple-negative breast Cancer response to neoadjuvant chemotherapy employing transcriptomic and functional validation","volume":"23","author":"Vishnubalaji","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2026.110729_bb0085","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s12011-025-04718-7","article-title":"Machine learning-based biomarker discovery from serum trace elements and biochemical parameters in patients with nasal polyps","volume":"204","author":"Aydin","year":"2026","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.clim.2026.110729_bb0090","doi-asserted-by":"crossref","first-page":"109124","DOI":"10.1016\/j.isci.2024.109124","article-title":"Predicting transcription factor activity using prior biological information","volume":"27","author":"Yashar","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.clim.2026.110729_bb0095","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12920-025-02221-5","article-title":"Intrauterine growth restriction induces persistent adipose inflammation and metabolic abnormalities in rats among various postnatal growth trajectories","volume":"18","author":"Hu","year":"2025","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.clim.2026.110729_bb0100","first-page":"676","article-title":"Human papilloma virus infection drives unique metabolic and immune profiles in head and neck and cervical cancers: implications for targeted therapies and prognostic markers. Discov","volume":"16","author":"Hamid","year":"2025","journal-title":"Oncol"},{"key":"10.1016\/j.clim.2026.110729_bb0105","doi-asserted-by":"crossref","first-page":"btae089","DOI":"10.1093\/bioinformatics\/btae089","article-title":"ICELLNET v2: a versatile method for cell-cell communication analysis from human transcriptomic data","volume":"40","author":"Massenet-Regad","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.clim.2026.110729_bb0110","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1038\/s41467-025-60445-6","article-title":"Type 1 interferon signature and allograft inflammatory factor-1 contribute to refractoriness to TNF inhibition in ankylosing spondylitis","volume":"16","author":"Song","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2026.110729_bb0115","doi-asserted-by":"crossref","DOI":"10.4110\/in.2025.25.e15","article-title":"Modulation of immune responses by metabolic reprogramming: the key role of Immunometabolism","volume":"25","author":"Park","year":"2025","journal-title":"Immune Netw."},{"key":"10.1016\/j.clim.2026.110729_bb0120","doi-asserted-by":"crossref","first-page":"144","DOI":"10.5114\/reum\/201175","article-title":"Levels of osteocalcin and N-terminal telopeptide of type I collagen in men with ankylosing spondylitis: associations with disease course and structural-functional status of bone tissue","volume":"63","author":"Shevchuk","year":"2025","journal-title":"Reumatologia"},{"key":"10.1016\/j.clim.2026.110729_bb0125","doi-asserted-by":"crossref","first-page":"1291206","DOI":"10.3389\/fimmu.2023.1291206","article-title":"Associations of the circulating levels of cytokines with risk of ankylosing spondylitis: a Mendelian randomization study","volume":"14","author":"Ye","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110729_bb0130","doi-asserted-by":"crossref","first-page":"14892","DOI":"10.1038\/s41598-024-63707-3","article-title":"Comparing machine learning screening approaches using clinical data and cytokine profiles for COVID-19 in resource-limited and resource-abundant settings","volume":"14","author":"Rashidi","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2026.110729_bb0135","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00296-019-04298-5","article-title":"Evaluation of serum fibroblast growth factor-23 in patients with axial spondyloarthritis and its association with sclerostin, inflammation, and spinal damage","volume":"39","author":"Gercik","year":"2019","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.clim.2026.110729_bb0140","article-title":"Relationship between biologic therapy and cytokine levels in patients with inflammatory arthritis","volume":"104","author":"Zhang","year":"2025","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clim.2026.110729_bb0145","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/cei.12577","article-title":"Toll-like receptor 2 and 4 induced interleukin-19 dampens immune reactions and associates inversely with spondyloarthritis disease activity","volume":"180","author":"Kragstrup","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2026.110729_bb0150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.21037\/med.2019.02.02","article-title":"ZHANG P: levels of Tc17 cells in thymic epithelial cell tumors associated with autoimmune diseases","volume":"3","author":"Li","year":"2019","journal-title":"Mediastinum"},{"key":"10.1016\/j.clim.2026.110729_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2024.12.025","article-title":"Phase II randomized trial of BI 730357, an Oral ROR\u03b3t inhibitor, for moderate-to-severe plaque psoriasis","volume":"145","author":"Gooderham","year":"2025","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clim.2026.110729_bb0160","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/FPC.0000000000000446","article-title":"Association between nuclear factor of activated T cells C2 polymorphisms and treatment response in rheumatoid arthritis patients receiving tumor necrosis factor-alpha inhibitors","volume":"32","author":"Kim","year":"2022","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.clim.2026.110729_bb0165","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.3390\/molecules30102214","article-title":"KIMURA KI, KATAOKA T: Kujigamberol inhibits IFN-\u03b3 and IL-2 mRNA expression and NFATc2 binding to their promoters in response to a Phorbol Ester and Ionomycin stimulation","volume":"30","author":"Yodweerapong","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.clim.2026.110729_bb0170","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1177\/09612033251361560","article-title":"SHUKLA a et al.: comparative efficacy of intravenous cyclophosphamide, mycophenolate mofetil, and tacrolimus as induction therapy for lupus nephritis: a randomized controlled open-label trial","volume":"34","author":"Amudalapalli","year":"2025","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2026.110729_bb0175","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cmet.2023.01.009","article-title":"Sodium perturbs mitochondrial respiration and induces dysfunctional Tregs","volume":"35","author":"C\u00f4rte-Real","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.clim.2026.110729_bb0180","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.atherosclerosis.2016.01.044","article-title":"Effects of simvastatin, ezetimibe and simvastatin\/ezetimibe on mitochondrial function and leukocyte\/endothelial cell interactions in patients with hypercholesterolemia","volume":"247","author":"Hernandez-Mijares","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clim.2026.110729_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.922531","article-title":"Ezetimibe ameliorates clinical symptoms in a mouse model of ankylosing spondylitis associated with suppression of Th17 differentiation","volume":"13","author":"Moon","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2026.110729_bb0190","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa2312302","article-title":"Neutralizing autoantibodies against Interleukin-10 in inflammatory bowel disease","volume":"391","author":"Griffin","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2026.110729_bb0195","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3390\/microorganisms11061530","article-title":"Amelioration of murine colitis by attenuated salmonella choleraesuis encoding Interleukin-19","volume":"11","author":"Chen","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.clim.2026.110729_bb0200","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.clim.2026.110729_bb0205","doi-asserted-by":"crossref","first-page":"bbaa219","DOI":"10.1093\/bib\/bbaa219","article-title":"SHAHRIYARI L: a review of digital cytometry methods: estimating the relative abundance of cell types in a bulk of cells","volume":"22","author":"Le","year":"2021","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.clim.2026.110729_bb0210","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/01616412.2025.2503462","article-title":"ZHOU X: analysis of the autophagy-related gene NLRC4 in spinal cord injury","volume":"47","author":"Gu","year":"2025","journal-title":"Neurol. Res."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661626000677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661626000677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:08:37Z","timestamp":1785884917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661626000677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":42,"alternative-id":["S1521661626000677"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2026.110729","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcriptional immune programs underlying inadequate response to tumor necrosis factor inhibitors in ankylosing spondylitis","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2026.110729","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110729"}}